Ranitidine prophylaxis in acute gastric mucosal damage in critically ill pediatric patients. 1988

J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
Pediatric Intensive Care Unit, La Paz Children's Hospital, Madrid, Spain.

We determined the ranitidine dosage necessary to maintain gastric pH at or above 4 in 40 critically ill children. The patients were divided into four groups of ten patients each. They were treated with ranitidine in the following dosages: a) 2 mg/kg by NG tube every 12 h; b) 4 mg/kg by NG tube every 12 h; c) 0.75 mg/kg iv every 6 h; d) 1.5 mg/kg iv every 6 h. The fourth group had a higher median pH than the other groups, in spite of also having the highest risk of acute gastric mucosal damage (AGMD). Eight (80%) of ten patients in the fourth group had a pH greater than or equal to 4 or more than 80% of the study period. We recommend 1.5 mg/kg iv every 6 h for gastric acid inhibition in AGMD prophylaxis in children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007441 Intubation, Gastrointestinal The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc. Intubation, Nasogastric,Gastrointestinal Intubation,Gastrointestinal Intubations,Intubations, Gastrointestinal,Intubations, Nasogastric,Nasogastric Intubation,Nasogastric Intubations
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive

Related Publications

J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
January 2019, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
January 1998, Intensive care medicine,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
January 2000, Critical care medicine,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
March 1986, British journal of clinical pharmacology,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
June 1988, Alimentary pharmacology & therapeutics,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
January 1981, Acta gastroenterologica Latinoamericana,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
August 1998, Critical care medicine,
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
February 2011, Wiener medizinische Wochenschrift (1946),
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
January 2008, Critical care (London, England),
J Lopez-Herce Cid, and L Albajara Velasco, and R Codoceo, and M A Delgado Dominguez, and E Jimenez, and F Ruza Tarrio
January 2008, Critical care nursing quarterly,
Copied contents to your clipboard!